David Nathanson
About
In The Last Decade
David Nathanson
20 papers receiving 815 citations
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 617
- Molecular Biology 303
- Surgery 175
- Cardiology and Cardiovascular Medicine 106
- Cellular and Molecular Neuroscience 103
Countries citing papers authored by David Nathanson
This map shows the geographic impact of David Nathanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nathanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nathanson more than expected).
Fields of papers citing papers by David Nathanson
This network shows the impact of papers produced by David Nathanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nathanson. The network helps show where David Nathanson may publish in the future.
Co-authorship network of co-authors of David Nathanson
This figure shows the co-authorship network connecting the top 25 collaborators of David Nathanson. A scholar is included among the top collaborators of David Nathanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nathanson. David Nathanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 39 | |
| 3 | 25 | |
| 4 | 14 | |
| 5 | 163 | |
| 6 | 2 | |
| 7 | Doubled healthcare costs of type 2 diabetes mellitus during years 2006-2014 : a nationwide cost-of-illness study in Sweden | 1 |
| 8 | 41 | |
| 9 | 66 | |
| 10 | 8 | |
| 11 | 38 | |
| 12 | Second-line treatment with sulfonylurea compared to DPP4 inhibitors is associated with risk of cardiovascular disease, all-cause mortality and severe hypoglycaemia | 0 |
| 13 | 38 | |
| 14 | 21 | |
| 15 | 25 | |
| 16 | 3 | |
| 17 | 211 | |
| 18 | 0 | |
| 19 | 18 | |
| 20 | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.